IMP
Process View
plasma lipoprotein particle clearance
The process in which a lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "plasma lipoprotein particle clearance"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| C1QA | complement component 1, q subcomponent, A chain | 1.000 | Human | |
| ALB | albumin | 0.997 | ||
| APOA1 | apolipoprotein A-I | 0.995 | Human | |
| HP | haptoglobin | 0.976 | ||
| C1QC | complement component 1, q subcomponent, C chain | 0.845 | Human | |
| C1QB | complement component 1, q subcomponent, B chain | 0.696 | Human | |
| RBFOX1 | RNA binding protein, fox-1 homolog (C. elegans) 1 | 0.424 | ||
| RPL18A | ribosomal protein L18a | 0.332 | ||
| APOC1 | apolipoprotein C-I | 0.323 | ||
| AP2A1 | adaptor-related protein complex 2, alpha 1 subunit | 0.309 | ||
| A2M | alpha-2-macroglobulin | 0.286 | ||
| APOC2 | apolipoprotein C-II | 0.276 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.214 | ||
| APOA2 | apolipoprotein A-II | 0.195 | ||
| U2AF2 | U2 small nuclear RNA auxiliary factor 2 | 0.193 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.189 | ||
| APOE | apolipoprotein E | 0.183 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.172 | ||
| RBFOX2 | RNA binding protein, fox-1 homolog (C. elegans) 2 | 0.136 | ||
| LDLR | low density lipoprotein receptor | 0.127 | ||
| PCBP2 | poly(rC) binding protein 2 | 0.124 | ||
| APOC3 | apolipoprotein C-III | 0.110 | ||
| KHDRBS1 | KH domain containing, RNA binding, signal transduction associated 1 | 0.085 | ||
| EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.085 | ||
| PCSK9 | proprotein convertase subtilisin/kexin type 9 | 0.067 | ||
| HNRNPH1 | heterogeneous nuclear ribonucleoprotein H1 (H) | 0.064 | ||
| TTR | transthyretin | 0.061 | ||
| PCBP1 | poly(rC) binding protein 1 | 0.057 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.054 | ||
| TREM2 | triggering receptor expressed on myeloid cells 2 | 0.053 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.052 | ||
| MARCO | macrophage receptor with collagenous structure | 0.048 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.042 | ||
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.041 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.039 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.037 | ||
| MAP2K3 | mitogen-activated protein kinase kinase 3 | 0.037 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.036 | ||
| PTBP2 | polypyrimidine tract binding protein 2 | 0.035 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.033 | ||
| PLTP | phospholipid transfer protein | 0.033 | ||
| FGA | fibrinogen alpha chain | 0.028 | ||
| MTAP | methylthioadenosine phosphorylase | 0.026 | ||
| DHX9 | DEAH (Asp-Glu-Ala-His) box polypeptide 9 | 0.024 | ||
| VLDLR | very low density lipoprotein receptor | 0.022 | ||
| PRKCZ | protein kinase C, zeta | 0.021 | ||
| STON2 | stonin 2 | 0.021 | ||
| CD163 | CD163 molecule | 0.021 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.021 | ||
| MICALL1 | MICAL-like 1 | 0.021 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.019 | ||
| LBP | lipopolysaccharide binding protein | 0.019 | ||
| AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | 0.019 | ||
| SLAMF8 | SLAM family member 8 | 0.018 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.018 | ||
| ACP5 | acid phosphatase 5, tartrate resistant | 0.018 | ||
| VSIG4 | V-set and immunoglobulin domain containing 4 | 0.017 | ||
| CD68 | CD68 molecule | 0.016 | ||
| TXNDC2 | thioredoxin domain containing 2 (spermatozoa) | 0.016 | ||
| AP2B1 | adaptor-related protein complex 2, beta 1 subunit | 0.016 | ||
| FCHO2 | FCH domain only 2 | 0.016 | ||
| APP | amyloid beta (A4) precursor protein | 0.016 | ||
| STK10 | serine/threonine kinase 10 | 0.015 | ||
| WNT3A | wingless-type MMTV integration site family, member 3A | 0.015 | ||
| PTPN5 | protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) | 0.015 | ||
| MAGEB18 | melanoma antigen family B, 18 | 0.015 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.015 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.015 | ||
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.014 | ||
| MSR1 | macrophage scavenger receptor 1 | 0.014 | Mouse | |
| CIRBP | cold inducible RNA binding protein | 0.014 | ||
| C2 | complement component 2 | 0.014 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.014 | ||
| FAM83C | family with sequence similarity 83, member C | 0.013 | ||
| TLR7 | toll-like receptor 7 | 0.013 | ||
| SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.013 | ||
| STAB1 | stabilin 1 | 0.012 | ||
| EHD4 | EH-domain containing 4 | 0.012 | ||
| LRPAP1 | low density lipoprotein receptor-related protein associated protein 1 | 0.012 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.011 | ||
| MRC1 | mannose receptor, C type 1 | 0.011 | ||
| MDK | midkine (neurite growth-promoting factor 2) | 0.011 | ||
| PXN | paxillin | 0.011 | ||
| LIPC | lipase, hepatic | 0.011 | Human Rat | |
| TOP1 | topoisomerase (DNA) I | 0.011 | ||
| THPO | thrombopoietin | 0.010 | ||
| MAPT | microtubule-associated protein tau | 0.010 | ||
| CLEC4G | C-type lectin domain family 4, member G | 0.010 |